Gemfibrozil Tablet
Product Images NDC 51655-143

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gemfibrozil (NDC 51655-143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

51655 143 83 Master Bottle Label Approval Rev A 07 20

51655 143 83 Master Bottle Label Approval Rev A 07 20
Label for Gemfibrozil Tablets, USP 600 mg oral tablets distributed in a package of 180 tablets. The label includes storage instructions and handling precautions. The product is Rx only and repackaged by Northwind Pharmaceuticals in Indianapolis, IN, with the NDC number 51655-143.*
FDA Label Image

Image (Gemfibrozil Str)

Image (Gemfibrozil Str)
Chemical structure of the active ingredient Gemfibrozil, showing its molecular connectivity and functional groups as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.